[
  {
    "ts": null,
    "headline": "Sector Update: Health Care Stocks Rise Late Afternoon",
    "summary": "Health care stocks advanced late Thursday afternoon, with the NYSE Health Care Index rising 0.9% and",
    "url": "https://finnhub.io/api/news?id=f3e27a63147a30bb0a66741eddf37645fb4195c7ebc4b6f3a658f9c6070851a1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752177431,
      "headline": "Sector Update: Health Care Stocks Rise Late Afternoon",
      "id": 135863848,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Health care stocks advanced late Thursday afternoon, with the NYSE Health Care Index rising 0.9% and",
      "url": "https://finnhub.io/api/news?id=f3e27a63147a30bb0a66741eddf37645fb4195c7ebc4b6f3a658f9c6070851a1"
    }
  },
  {
    "ts": null,
    "headline": "Why Moderna (MRNA) Stock Is Up Today",
    "summary": "Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 3.8% in the morning session after the U.S. Food and Drug Administration (FDA) granted full approval for its Spikevax COVID-19 vaccine to be used in children. The approval covers children from six months through 11 years of age who are at an elevated risk for severe COVID-19.",
    "url": "https://finnhub.io/api/news?id=9078ca8f0b1271aa0fd9f0ab0a544caa1e029533262c0c88d20776de7cc247aa",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752162642,
      "headline": "Why Moderna (MRNA) Stock Is Up Today",
      "id": 135856803,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 3.8% in the morning session after the U.S. Food and Drug Administration (FDA) granted full approval for its Spikevax COVID-19 vaccine to be used in children. The approval covers children from six months through 11 years of age who are at an elevated risk for severe COVID-19.",
      "url": "https://finnhub.io/api/news?id=9078ca8f0b1271aa0fd9f0ab0a544caa1e029533262c0c88d20776de7cc247aa"
    }
  },
  {
    "ts": null,
    "headline": "Top Midday Stories: MP Materials Partners With DoD on Rare Earth Magnet Supply Chain; Delta Restores Full-Year Guidance",
    "summary": "The Dow Jones Industrial Average and S&P 500 were up, while the Nasdaq Composite was down in late-mo",
    "url": "https://finnhub.io/api/news?id=48f5e09f7c48099c74933288b46fd31b1ce121e8904f7316f4b32eb799b5fdd7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752162192,
      "headline": "Top Midday Stories: MP Materials Partners With DoD on Rare Earth Magnet Supply Chain; Delta Restores Full-Year Guidance",
      "id": 135863855,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "The Dow Jones Industrial Average and S&P 500 were up, while the Nasdaq Composite was down in late-mo",
      "url": "https://finnhub.io/api/news?id=48f5e09f7c48099c74933288b46fd31b1ce121e8904f7316f4b32eb799b5fdd7"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Receives Full U.S. FDA Approval for COVID-19 Vaccine, Spikevax, in Children Aged 6 Months Through 11 Years at Increased Risk for COVID-19 Disease",
    "summary": "Spikevax is now approved for all adults aged 65 years and older, and individuals aged 6 months through 64 years at increased risk for COVID-19 disease CAMBRIDGE, MA / ACCESS Newswire / July 10, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that ...",
    "url": "https://finnhub.io/api/news?id=76db2887bde4fecb1e0d3d9b7cc09f698eeaef7ff63367d190b0288718218547",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752148800,
      "headline": "Moderna Receives Full U.S. FDA Approval for COVID-19 Vaccine, Spikevax, in Children Aged 6 Months Through 11 Years at Increased Risk for COVID-19 Disease",
      "id": 135856804,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Spikevax is now approved for all adults aged 65 years and older, and individuals aged 6 months through 64 years at increased risk for COVID-19 disease CAMBRIDGE, MA / ACCESS Newswire / July 10, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that ...",
      "url": "https://finnhub.io/api/news?id=76db2887bde4fecb1e0d3d9b7cc09f698eeaef7ff63367d190b0288718218547"
    }
  },
  {
    "ts": null,
    "headline": "Moderna: Spikevax approved for children at increased risk",
    "summary": "Moderna announces that the US FDA has approved the supplemental biologics license application for its Spikevax vaccine in children aged six months to 11 years who are at increased risk of...",
    "url": "https://finnhub.io/api/news?id=1181995bcb8b075e8f6e8e1e74db85e7e2a6ebd7875676ec2e25a15ba6304e3c",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752139945,
      "headline": "Moderna: Spikevax approved for children at increased risk",
      "id": 135851685,
      "image": "",
      "related": "MRNA",
      "source": "Finnhub",
      "summary": "Moderna announces that the US FDA has approved the supplemental biologics license application for its Spikevax vaccine in children aged six months to 11 years who are at increased risk of...",
      "url": "https://finnhub.io/api/news?id=1181995bcb8b075e8f6e8e1e74db85e7e2a6ebd7875676ec2e25a15ba6304e3c"
    }
  },
  {
    "ts": null,
    "headline": "Moderna gets full US approval for COVID shot in at-risk children 6 months and older",
    "summary": "The U.S. Food and DrugAdministration has granted full approval for Moderna'sCOVID-19 vaccine, Spikevax, in children aged 6 months through 11years who are at an increased risk of the disease, the...",
    "url": "https://finnhub.io/api/news?id=6516e105131f4fdeb1df0c1755668824f72d49fb9986ab4fb895949122e26278",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752136453,
      "headline": "Moderna gets full US approval for COVID shot in at-risk children 6 months and older",
      "id": 135850958,
      "image": "",
      "related": "MRNA",
      "source": "Finnhub",
      "summary": "The U.S. Food and DrugAdministration has granted full approval for Moderna'sCOVID-19 vaccine, Spikevax, in children aged 6 months through 11years who are at an increased risk of the disease, the...",
      "url": "https://finnhub.io/api/news?id=6516e105131f4fdeb1df0c1755668824f72d49fb9986ab4fb895949122e26278"
    }
  },
  {
    "ts": null,
    "headline": "Moderna gets full US approval for COVID vaccine in children 6 months and older",
    "summary": "The U.S. Food and DrugAdministration has granted full approval for Moderna'sCOVID-19 vaccine, Spikevax, in children aged 6 months through 11years who are at an increased risk of the disease, the...",
    "url": "https://finnhub.io/api/news?id=0a0c11545c76fdb7a1630beb9f9d461f52f0b82c5280ac4819953084581f5999",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752136453,
      "headline": "Moderna gets full US approval for COVID vaccine in children 6 months and older",
      "id": 135850137,
      "image": "",
      "related": "MRNA",
      "source": "Finnhub",
      "summary": "The U.S. Food and DrugAdministration has granted full approval for Moderna'sCOVID-19 vaccine, Spikevax, in children aged 6 months through 11years who are at an increased risk of the disease, the...",
      "url": "https://finnhub.io/api/news?id=0a0c11545c76fdb7a1630beb9f9d461f52f0b82c5280ac4819953084581f5999"
    }
  },
  {
    "ts": null,
    "headline": "Moderna gets full US approval for COVID-19 vaccine in children 6 months and older",
    "summary": "The U.S. Food and DrugAdministration has granted full approval for Moderna'sCOVID-19 vaccine, Spikevax, in children aged 6 months through 11years who are at an increased risk of the disease, the...",
    "url": "https://finnhub.io/api/news?id=100feb855dd2c13d1b84148c19ac373d5873cace0b30509f5e651544fcba781a",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752136088,
      "headline": "Moderna gets full US approval for COVID-19 vaccine in children 6 months and older",
      "id": 135849991,
      "image": "",
      "related": "MRNA",
      "source": "Finnhub",
      "summary": "The U.S. Food and DrugAdministration has granted full approval for Moderna'sCOVID-19 vaccine, Spikevax, in children aged 6 months through 11years who are at an increased risk of the disease, the...",
      "url": "https://finnhub.io/api/news?id=100feb855dd2c13d1b84148c19ac373d5873cace0b30509f5e651544fcba781a"
    }
  },
  {
    "ts": null,
    "headline": "Moderna : Receives Full U.S. FDA Approval for COVID-19 Vaccine, Spikevax, in Children Aged 6 Months Through 11 Years at Increased Risk for COVID-19 Disease",
    "summary": "Spikevax is now approved for all adults aged 65 years and older, and individuals aged 6 months through 64 years at increased risk for COVID-19 disease CAMBRIDGE, MA / ACCESS...",
    "url": "https://finnhub.io/api/news?id=37d0b8e91016bc5c2c67275ecd1c14ba35f07428a777caa38b9e323e2a6a9f85",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752136087,
      "headline": "Moderna : Receives Full U.S. FDA Approval for COVID-19 Vaccine, Spikevax, in Children Aged 6 Months Through 11 Years at Increased Risk for COVID-19 Disease",
      "id": 135849992,
      "image": "",
      "related": "MRNA",
      "source": "Finnhub",
      "summary": "Spikevax is now approved for all adults aged 65 years and older, and individuals aged 6 months through 64 years at increased risk for COVID-19 disease CAMBRIDGE, MA / ACCESS...",
      "url": "https://finnhub.io/api/news?id=37d0b8e91016bc5c2c67275ecd1c14ba35f07428a777caa38b9e323e2a6a9f85"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer, BioNTech ask UK court to overturn Moderna's COVID vaccine patent win",
    "summary": "Pfizer and its Germanpartner BioNTech asked London's Court of Appeal on Thursday tooverturn a ruling that their COVID-19 vaccine infringed one ofModerna's patents, in the latest round of a...",
    "url": "https://finnhub.io/api/news?id=8f082319029ae9ccbf3e1c45e234c9c69c1408985d6d5f29269d7bba102db49b",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752131661,
      "headline": "Pfizer, BioNTech ask UK court to overturn Moderna's COVID vaccine patent win",
      "id": 135848204,
      "image": "",
      "related": "MRNA",
      "source": "Finnhub",
      "summary": "Pfizer and its Germanpartner BioNTech asked London's Court of Appeal on Thursday tooverturn a ruling that their COVID-19 vaccine infringed one ofModerna's patents, in the latest round of a...",
      "url": "https://finnhub.io/api/news?id=8f082319029ae9ccbf3e1c45e234c9c69c1408985d6d5f29269d7bba102db49b"
    }
  }
]